Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time: reply to a rebuttal

被引：0
|
作者：
Cuker, A. [1 ]
Cines, D. B. [1 ,2 ]
Pollak, E. S. [2 ,3 ]
机构：
[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷 / 12期
关键词：
THERAPEUTIC RANGE; REAGENTS;
D O I：
10.1111/j.1538-7836.2009.03625.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2158 / 2159
页数：3
相关论文
共 50 条
  • [21] Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment
    Moumneh, T.
    Mallecian, Y.
    Calmes, A.
    Lacour, E.
    Roy, P. M.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 360 - 361
  • [22] Components of variability of activated partial thromboplastin time (APTT) vs. anti-factor Xa (AXa) on unfractionated heparin (UFH) dose adjustments
    Guerrero, F.
    Faure, A.
    Diemert, V
    Voisin, S.
    Sie, P.
    Riviere, Bura A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 683 - 684
  • [23] Standardization of Anti-Xa Assay and its Comparison with Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin Therapy
    Thalappil, Vijisha
    Anand, Jeyanthi
    Keepanasseril, Anish
    Kar, Rakhee
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (03) : 432 - 436
  • [24] Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients
    Kulig, Caitlin E.
    Schomer, Kendra J.
    Black, Hugh B.
    Dager, William E.
    [J]. ASAIO JOURNAL, 2021, 67 (04) : 411 - 415
  • [25] Comparison of anti-factor Xa heparin activity and activated partial thromboplastin time in 2,773 plasma samples from unfractionated heparin-treated patients
    Rosborough, TK
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 108 (06) : 662 - 668
  • [26] Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors
    Ono, Ryohei
    Nishimura, Kazutaka
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Fukushima, Kenichi
    Kobayashi, Yoshio
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (02) : 323 - 336
  • [27] Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors
    Ryohei Ono
    Kazutaka Nishimura
    Hidehisa Takahashi
    Yasuhiko Hori
    Kenichi Fukushima
    Yoshio Kobayashi
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 323 - 336
  • [28] From Activated Partial Thromboplastin Time to Antifactor Xa and Back AgainThe Evolution of Monitoring Unfractionated Heparin
    May, Jori E.
    Siniard, Rance Chad
    Taylor, Laura J.
    Marques, Marisa B.
    Gangaraju, Radhika
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 157 (03) : 321 - 327
  • [29] Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
    Lawlor, Matthew
    Gupta, Aakriti
    Ranard, Lauren S.
    Madhavan, Mahesh V.
    Li, Jianhua
    Eisenberger, Andrew
    Parikh, Sahil A.
    Sethi, Sanjum S.
    Masoumi, Amirali
    [J]. THROMBOSIS RESEARCH, 2021, 198 : 79 - 82
  • [30] Concordance between Anti-Factor Xa and Activated Partial Thromboplastin Time Measurements in Syncardia Total Artificial Heart Recipients Receiving Postoperative Anticoagulation with Unfractionated Heparin
    Vela, M. Monteagudo
    Bowles, C.
    Raj, B.
    Simon, A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S447 - S447
12345